Validation for performing ¹¹C-methionine and ¹F-FDG-PET studies on the same day

Takuya Mitsumoto1, Kazuo Kubota, Takashi Sato

  • 1Department of Radiology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan. takuya_mitsumoto0126@yahoo.co.jp

Abstract

Insights

Performing same-day L-[methyl-¹¹C]methionine (MET) and 2-[¹⁸F]fluoro-2-deoxy-D-glucose (FDG) PET scans is feasible. An injection interval exceeding 90 minutes prevents positron cross-talk (PCT) between MET and FDG PET imaging.

Area of Science:

  • Nuclear Medicine
  • Radiochemistry
  • Oncology Imaging

Background:

  • Simultaneous PET scans using L-[methyl-¹¹C]methionine (MET) and 2-[¹⁸F]fluoro-2-deoxy-D-glucose (FDG) may enhance brain tumor investigation.
  • Positron cross-talk (PCT) is a potential issue when performing these scans on the same day.

Purpose of the Study:

  • To investigate the impact of PCT between MET and FDG PET scans.
  • To determine the optimal protocol for same-day MET and FDG PET imaging.

Main Methods:

  • 62 head and neck cancer patients underwent MET-PET and FDG-PET scans with varying injection intervals.
  • Liver and muscle uptake were analyzed to quantify PCT, focusing on MET's liver uptake.
  • Patients were grouped based on injection intervals: 30-49 min (G1), 50-69 min (G2), 70-89 min (G3), and ≥90 min (G4).

Main Results:

  • PCT in the liver significantly decreased from G1 to G3 (P<0.001) and stabilized in G4.
  • No significant difference in PCT was observed in muscle tissue across all groups (P=0.693).
  • PCT was eliminated at injection intervals greater than 90 minutes.

Conclusions:

  • Same-day MET and FDG-PET imaging is clinically viable without PCT if the interval exceeds 90 minutes.
  • This protocol reduces patient burden and facilitates multiple PET examinations under consistent conditions.